logo

EN
KO

INVESTOR & MEDIA

As we are dedicated to the development of life science and technology,
we contribute to humanity by spreading good will with a sense of mission.

INVESTOR & MEDIA

282
Illimis Therapeutics
2025-07-15

Illimis Therapeutics Closes 58 billion KRW ($42 million) Series B Financing to accelerate CNS and Immune Disease Drug Development via GAIA Platform
232
Illimis Therapeutics
2024-01-09

Illimis Therapeutics Designated as a 2024 Alternative Military Service Company
198
Illimis Therapeutics
2023-09-14

Illimis Therapeutics Selected for the Ministry of SMEs and Startups' 'Scale-up TIPS' R&D Program
160
Illimis Therapeutics
2023-04-18

Illimis Therapeutics Raises $15M in Series A Round
119
Illimis Therapeutics
2022-11-29

Degenerative Brain Disease Treatment Developer ‘Illimis Therapeutics’ Selected as a Ministry of SMEs and Startups’ ‘Baby Unicorn’